trial · primary record
Atezolizumab
Lung Non-Small Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 336 |
| Primary completion | 2032-09-30 |
| Primary endpoint | Disease-free survival |
| Registry ID | NCT07388524 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:35.299Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07388524
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.